Astrana Health (NASDAQ:ASTH) Shares Down 5.9% - What's Next?

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report)'s share price traded down 5.9% during mid-day trading on Wednesday . The stock traded as low as $25.30 and last traded at $25.13. 15,072 shares changed hands during trading, a decline of 95% from the average session volume of 293,713 shares. The stock had previously closed at $26.70.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Truist Financial decreased their price target on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Barclays assumed coverage on shares of Astrana Health in a report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price target on the stock. Robert W. Baird decreased their price target on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. Finally, Bank of America decreased their price target on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday, March 4th. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Astrana Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Stock Up 0.0%

The stock has a 50-day moving average price of $27.20 and a 200-day moving average price of $31.18. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70. The company has a market capitalization of $1.39 billion, a P/E ratio of 34.35, a P/E/G ratio of 1.33 and a beta of 0.85.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09). The firm had revenue of $620.39 million for the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The firm's revenue for the quarter was up 53.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.31 EPS. On average, research analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Astrana Health in the 4th quarter worth about $40,000. Quarry LP boosted its position in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after purchasing an additional 471 shares in the last quarter. Covestor Ltd grew its stake in Astrana Health by 777.6% during the first quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after purchasing an additional 1,773 shares during the period. US Bancorp DE boosted its holdings in shares of Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock worth $151,000 after buying an additional 4,656 shares in the last quarter. Finally, AlphaQuest LLC boosted its holdings in shares of Astrana Health by 144.2% during the 1st quarter. AlphaQuest LLC now owns 4,883 shares of the company's stock worth $151,000 after buying an additional 2,883 shares in the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.